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Introduction: Articular cartilage needs sulfated-glycosaminoglycans (sGAGs) to withstand high pressures while
mechanically loaded. Chondrocyte sGAG synthesis is regulated by exposure to compressive forces. Moderate
physical exercise is known to improve cartilage sGAG content and might protect against osteoarthritis (OA). This
study investigated whether rat knee joints with sGAG depleted articular cartilage through papain injections might
benefit from moderate exercise, or whether this increases the susceptibility for cartilage degeneration.
Methods: sGAGs were depleted from cartilage through intraarticular papain injections in the left knee joints of 40
Wistar rats; their contralateral joints served as healthy controls. Of the 40 rats included in the study, 20 rats
remained sedentary, and the other 20 were subjected to a moderately intense running protocol. Animals were
longitudinally monitored for 12 weeks with in vivo micro-computed tomography (μCT) to measure subchondral
bone changes and single-photon emission computed tomography (SPECT)/CT to determine synovial macrophage
activation. Articular cartilage was analyzed at 6 and 12 weeks with ex vivo contrast-enhanced μCT and histology to
measure sGAG content and cartilage thickness.
Results: All outcome measures were unaffected by moderate exercise in healthy control joints of running animals
compared with healthy control joints of sedentary animals. Papain injections in sedentary animals resulted in severe
sGAG-depleted cartilage, slight loss of subchondral cortical bone, increased macrophage activation, and osteophyte
formation. In running animals, papain-induced sGAG-depleted cartilage showed increased cartilage matrix
degradation, sclerotic bone formation, increased macrophage activation, and more osteophyte formation.
Conclusions: Moderate exercise enhanced OA progression in papain-injected joints and did not protect against
development of the disease. This was not restricted to more-extensive cartilage damage, but also resulted in
pronounced subchondral sclerosis, synovial macrophage activation, and osteophyte formation.Introduction
Articular cartilage is evolutionarily designed to facilitate
joint motion. Cartilage extracellular matrix (ECM) is com-
posed of a collagen matrix in which chondrocytes reside.
These cells produce high concentrations of sulfated-
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stated.charged sulfate groups that set the cartilage fixed-charged
density. Because of this fixed-charged density, large
amounts of cations and water enter the cartilage ECM,
expanding the collagen network and creating a high
hydrostatic pressure. Cartilage daily endures high-peak
mechanical loading, including shear, compression, and
tension (contact) stresses. During physical activity, it is es-
timated that compressive stresses can increase to 10 to
20 MPa [1]. The high internal hydrostatic pressure allows
articular cartilage to absorb these stresses and facilitatesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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joint mobilization [2-4].
The amounts and types of external mechanical loading
are important factors that regulate development and long-
term maintenance of cartilage. This is because chondro-
cytes closely regulate sGAG levels dependent on the level
of physical activity [5]. For example, in hamsters, a seden-
tary lifestyle is known to reduce cartilage sGAG content,
whereas daily exercise prevents this loss [6]. Galois et al.
[7] investigated whether different running intensities influ-
enced osteoarthritis (OA) progression and found that
moderate running protected against OA development in
anterior cruciate ligament-transected knee joints. In an-
other experiment with mono-iodoacetate (MIA)-induced
OA, exercise also prevented cartilage damage. MIA in-
hibits glyceraldehyde-3-phosphate dehydrogenase activity,
resulting in chondrocyte apoptosis and sGAG loss [8].
When MIA-injected rats were subjected to treadmill run-
ning, the superficial and intermediate areas of the joint
showed a better preservation of sGAG content [9]. These
studies support the idea that a mild biomechanical stressor
on cartilage enhances chondrocyte ability to sustain sGAG
levels and protect cartilage against OA onset.
Kiviranta et al. [10] also showed that moderate running
augments sGAGs in articular cartilage of beagle dogs.
However, later, they found that a strenuous exercise
protocol induced marked sGAG depletion from superfi-
cial cartilage zones [11]. Since then, strenuous exercise
has been shown to reduce chondrocyte metabolism and
sGAG synthesis [12]. Besides inhibited sGAG production
during strenuous exercise, chondrocytes also start ac-
tively to deplete sGAG from cartilage, which is facilitated
through increased matrix metalloproteinase-13 (MMP-
13) production [13]. So cartilage loading through strenu-
ous running seems to elicit an imbalanced ratio of sGAG
synthesis and sGAG depletion. Reduced sGAG content
eventually results in reduced hydrostatic pressure, com-
promising the cartilage ability to absorb compressive
forces. This could explain why acute or chronic high-
intensity loads are described to cause cartilage ECM
damage [14], and may explain why healthy rats subjected
to strenuous running protocols develop cartilage damage
that is closely related to OA onset [15,16].
In summary, moderate biomechanical loads on cartil-
age can stimulate chondrocyte sGAG synthesis, improve
cartilage quality, and protect against OA [7,17], whereas
cartilage loading through strenuous running induces OA.
In early OA, sGAG levels in cartilage are reduced, mak-
ing the tissue more vulnerable to damage by mechanical
loading. This study investigated whether rat knee joints
with sGAG-depleted articular joints through papain
injections might benefit from moderate exercise, or
whether this increases the susceptibility to cartilage
degeneration.OA is a disease not limited to articular cartilage. OA is
considered a ”whole-joint disease” with involvement of
subchondral bone, synovium, and articular cartilage
changes [18,19] (Figure 1). All of these changes are most
likely to play an important role in the complex cascade
of pathologic changes during OA development. There-
fore, besides measurements on articular cartilage deg-
radation, we also measured subchondral bone changes
with μCT and macrophage activation with SPECT/CT.
Our results demonstrate that moderate exercise, which
does not have an effect on healthy joints, exerts detri-
mental effects on sGAG-depleted cartilage and also on
subchondral bone and synovial macrophage activation.
Methods
Study design
Forty 16-week-old male Wistar rats (Charles River
Netherlands BV, Maastricht, The Netherlands) were
housed in the animal facility of the Erasmus Medical
Centre, with a 12-hour light–dark regimen, at 21°C dur-
ing the experimental period. Animals received standard
food pellets and water ad libitum.
Intraarticular papain injections were used to reduce car-
tilage sGAG content in Wistar rat knee joints in vivo
[20-22]. Previous studies reported three intraarticular in-
jections to induce OA on days 1, 4, and 7 [22,23]. How-
ever, after one papain injection, weight bearing of the
injected joint is restored to normal 1 week after the injec-
tion [24]. Therefore, we injected our animals on days 8,
15, and 22. After they were adapted to the treadmill, with
intervals of 1 week to have the rats restore their gait, all
animals were injected intraarticularly in their left knee
joint with 30 μl papain/L-cystein solution. This solution
consisted of 2% wt/vol papain solution (type IV, double
crystallized, 15 units/mg; Sigma-Aldrich, St. Louis, MO,
USA) and 0.015M L-cystein (Sigma-Aldrich) in saline
[22]. Epinephrine (10 μg/ml; Centrafarm, Etten-Leur, The
Netherlands) was added to induce vasoconstriction and
prevent fast leakage from the knee joint [15,25,26]. All
right-knee joints were not injected and served as healthy
controls.
Rats were divided into two groups: 20 rats remained sed-
entary, and 20 rats were forced to run on a motorized
treadmill. All running rats were trained to run on a mo-
torized rodent treadmill during the first week (LE-8700;
Panlab Harvard Apparatus, Barcelona, Spain) [15]. The fol-
lowing 5 weeks, rats were forced to run for 5 days per
week, the first 5 minutes at 20 cm/sec to warm-up, and the
following 25 minutes at 35 cm/sec. The pace and duration
of this protocol are equal to about 25% of a total exhaus-
tion protocol for rats [27]. In total, running rats covered a
total distance of 15 km over the total 6-week period, which
is a protocol known to protect from cartilage degradation
in both MIA and surgical models for OA [7,9].
Figure 1 Hypothetical model that shows in what manner changes of cartilage, subchondral bone, and synovial macrophages all contribute
to osteoarthritis development. (A) Schematically depicted healthy joint with chondrocytes in cartilage extracellular matrix, bone and inactive
osteoclasts, and resting synovial macrophages. (B) Chondrocytes with a pathological strain produce cytokines and growth factors that diffuse toward
the underlying bone marrow and synovium. There these products stimulate osteoclastogenesis and can activate macrophages. (C) Progressive phase
of OA. Chondrocytes become hypertrophic and produce less sulfated-glycosaminoglycans (sGAGs) to sustain the cartilage, making the ECM more
susceptible to compressive forces. Osteoclasts start tunneling through the subchondral bone, which compromises plate stability, and changing its
supportive function for the overlying cartilage. Activated synovial macrophages produce growth factors of their own that promote synovial fibrosis,
osteophyte formation, and may stimulate ECM degradation. (D) Eventually, cartilage is severely sGAG depleted and becomes structurally deprived.
Activated macrophages stimulate fibrotic remodeling of the synovium and induce osteophyte growth. Osteoclast activity extends into the calcified
cartilage, up to the border with the deep zone of the cartilage. Through subchondral pores, vascular ingrowth occurs into the cartilage. Later,
osteoblasts infiltrate and start to deposit bone that results in end-stage sclerosis.
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tored with μCT to measure subchondral bone changes. At
6 and 12 weeks, 10 rats in both groups were randomly se-
lected for a full analysis sequence. This sequence consisted
of SPECT/CT to quantify macrophage activation in vivo,Figure 2 Experiment design indicating analytic time points and method
received three intraarticular papain injections (P.I.) and divided over two differ
running rats were subjected to a 6-week moderate running protocol, earlier re
scans were made to measure longitudinal subchondral bone changes. At 6 an
(n†), consisting of: determination of activated macrophages by using SPECT/C
contrast agent by using (EPIC-)μCT and histology ex vivo.and ex vivo EPIC-μCT and histology to measure cartilage
quality. A detailed planning scheme for all groups and
conducted tests is given in Figure 2. The Animal Ethics
Committee of the Erasmus Medical Center, Rotterdam,
The Netherlands, approved all conducted procedures.s for each experimental group. Forty 16-week-old male Wistar rats
ent groups: a sedentary group (n = 20) and a running group (n = 20). All
ported to protect against OA [17]. During the experiment, three μCT
d 12 weeks, a full analysis sequence was done in 10 animals per group
T in vivo; and cartilage analysis with equilibrium partitioning of an ionic
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osteophyte growth
All animals were μCT scanned before start of the run-
ning protocol (t = 0) and after 6 and 12 weeks of follow-
up. In short, under isoflurane anesthesia, after transfer
to a holder with the rat in supine position and the hind
leg fixed in extension, μCT scans were made by using a
Skyscan 1176 in vivo μCT scanner (Skyscan, Kontich,
Belgium). Ten minutes of scan time were required per
knee at an isotropic voxel size of 18 μm, at a voltage of
65 kV, a current of 385 mA, field of view of 35 mm, by
using a 1.0-mm aluminum filter, over 198 degrees, with
a 0.5-degree rotation step, and a 270-msec exposure
time. All scans were performed by using these same set-
tings; all scan data was reconstructed in an identical
way, and postprocessing was done as described previ-
ously [28-30].
All datasets were segmented with a local threshold al-
gorithm. This algorithm is ideal for accurate bone ana-
lysis (3D Calculator software can be requested via email)
[31]. With Skyscan analysis software, the tibial epiphysis
was selected in the CT scans and analyzed for changes
in cortical and trabecular bone. Cortical and trabecular
bone were automatically separated by using in-house
software [30]. Both subchondral plate thickness (Sb. Pl.
Th. in μm) and subchondral plate porosity (Sb. Pl. Por.
in mm3) of the medial and lateral compartment of the
tibial plateau were measured [28]. In the tibial epiphysis,
the trabecular thickness (Tb. Th. in μm) and trabecular
bone volume fraction (BV/TV), representing the ratio of
trabecular bone volume (BV, in mm3) to endocortical
tissue volume (TV, in mm3). Ectopic bone formation
(mm3) on both lateral borders of the patella was also
quantified as a measure for osteophyte growth in these
longitudinal μCT scans.Determination of activated macrophages by SPECT/CT by
using [111In]-EC0800
Activated macrophages express the folate-receptor-β [32].
Targeting this folate receptor with folate radioconjugates
can be used to monitor activated macrophages in vivo by
noninvasive nuclear imaging [33,34]. This technique was
previously introduced for OA research in a rat model [35].
In brief, phosphate-buffered saline (PBS, pH 6.5) DOTA-
Bz-folate (DOTA-Bz-Folate, EC0800, kindly provided by
Endocyte Inc., West Lafayette, LA, USA) was incubated
with [111In]Cl3 (Covedien, Petten, The Netherlands) in a
mixture of quenchers and sodium acetate (final pH 3.5 to
4) for 15 minutes at 80°C, as described earlier [36]. Quality
control was performed with instant thin-layer chromatog-
raphy medium, by using a silica gel (ITLC-SG) [37,38],
and revealed a radiochemical yield of about 93% at a spe-
cific activity of 50 MBq/μg.After radiolabeling, diethylenetriamine-pentaacetic
acid (DTPA) was added for complexation of nonincor-
porated 111In. The solution was further diluted in
phosphate-buffered saline (PBS) and administered via the
tail vein 20 hours before scanning. Each animal received
about 55 MBq of [111In]-DOTA-Bz-folate under isoflurane
anesthesia. SPECT/CT scans were performed with a four-
head multiplex multi-pinhole small-animal SPECT/CT
camera (NanoSPECT/CT; Bioscan Inc., Washington DC,
USA). Each detector head was fitted with a tungsten-
based collimator of nine 2.5-mm diameter pinholes; the
field of view was 24 mm in width; and energy peaks were
set at 170 keV and 240 keV (±10%). All knee joints were
scanned with both helical μCT (acquisition time, 5 mi-
nutes) and SPECT (acquisition time, 30 min).
After scanning, all datasets were reconstructed at an
isotropic CT voxel size of 200 μm and an isotropic
SPECT voxel size of 600 μm by using HiSPECT software
(Scivis, Göttingen, Germany). All scans were analyzed by
using InVivoScope processing software (Bioscan Inc.). A
cylindrical region of interest (ROI), based on the CT
scan but blinded for the radioactivity, was manually de-
termined for quantification of the radioactivity around
and in the knee joint. To correct for the size of the
drawn ROI, all data are presented as measured activity
(kBq)/mm3. To reduce interindividual variation, the ab-
solute difference in measured radioactivity (kBq/mm3) of
the OA knee joint compared with their internal control
joint was calculated. This absolute difference was used
when comparing means of papain only and papain com-
bined with running animals.
Cartilage measurements with EPIC-μCT
Equilibrium partitioning of an ionic contrast agent by
using μCT (EPIC-μCT) has a strong correlation with car-
tilage sulfated-glycosaminoglycan (sGAG) content [39].
sGAG is a key molecule of cartilage, and its content is an
indicator of cartilage health [40]. In EPIC-μCT, an equilib-
rium state exists between sGAG and contrast agent after a
24-hour incubation period. Resulting cartilage X-ray at-
tenuation in these scans is inversely related to sGAG con-
tent and thereby represents cartilage quality. This
technique is suited for quantitative analysis of cartilage
degradation for preclinical evaluation of OA [41].
Animals were euthanized directly after the last SPECT/
CT scan, and both knee joints were harvested for EPIC-
μCT analysis. The proximal tibial bone was isolated, and
soft tissue was removed to a maximal extent, without
harming cartilage integrity. Next, all specimens were
incubated in 40% solution of ioxaglate (Hexabrix320;
Mallinckrodt, Hazelwood, MO, USA), which was diluted
in 60% phosphate-buffered saline for 24 hours at room
temperature, together with inhibitors of proteolytic en-
zymes (5 mM ethylenediamine tetraacetic acid disodium
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benzamidine hydrochloride hydrate, Sigma-Aldrich Inc.
[42]. EPIC-μCT was performed on the 1176 in vivo μCT
scanner (Skyscan), by using the following scan settings:
isotropic voxel size of 18 μm, a voltage of 65 kV, a current
of 385 mA, field of view of 35 mm, a 0.5-mm aluminum
filter, 198 degrees with a 0.5-degree rotation step, and a
235-msec exposure time. All scans were performed by
using the same settings, and all data were reconstructed
identically.
With Skyscan analysis software, these datasets were seg-
mented by using a fixed attenuation threshold between air
(30) and subchondral bone (120), selected visually for the
best segmentation result in all datasets. In all segmented
μCT datasets, ROIs were drawn manually around the car-
tilage of the medial and lateral plateau of the tibia separ-
ately. From these ROIs, the X-ray attenuation (gray values
related to sGAG content ranging from 0 to 255) and car-
tilage thickness (μm) was calculated.
Histopathologic examination of the knee joint
After EPIC-μCT, the separated parts of the knee joints
were fixed in 3.7% phosphate-buffered formaldehyde,
decalcified with formic acid, and embedded in paraffin.
Sagittal sections of 6 μm thickness were made at 300-
μm intervals and stained with Safranin-O with a fast
green counterstain to image the amount and distribution
of the GAGs. Sections were stained all at once, to
minimize artifacts between different samples.
Statistical analysis
Differences between means of papain-injected and healthy
knee joints within the same animal were tested by using
paired t tests at each time point for all outcome para-
meters, except when testing differences for osteophyte
formation (GraphPad Software, San Diego, CA, USA).
Osteophytes did not develop in non-papain-injected con-
trol joints in both experimental groups; therefore, we used
a one-sample t test and tested whether the outcome of the
papain-injected joints differed from zero (GraphPad Soft-
ware). When comparing differences between means of
sedentary animals and running animals, unpaired t tests
were used at each time point for all outcome parameters
(GraphPad Software). For all tests, P values < 0.05 were
considered statistically significant.
Results
All sedentary rats increased in weight from 404.3 g (398.8
to 409.6 g) to 454.0 g (445.6 to 462.4 g) after 6 weeks, and
further increased to 488.0 g (475.2 to 500.8 g) after
12 weeks. Bodyweight of all running rats at baseline was
416.4 g (411.3 to 421.5 g), during the 6 weeks of treadmill
running; this did not increase (mean weight, 408.3 g; 398.2
to 418.3 g) and was significantly lower compared withsedentary rats (P < 0.0001). However, during the subse-
quent 6 weeks of rest, all running rats increased in body
weight (mean weight, 485.5 g; 473.0 to 498.0 g) to levels
similar to sedentary rats (see Additional file 1: Figure S1).
Osteoarthritic changes of articular cartilage
As measured with EPIC-μCT, intraarticular injections with
papain resulted in sGAG loss from medial and lateral car-
tilage compartments of the tibia plateau in sedentary ani-
mals compared with their control joints (P < 0.0001)
(Figure 3A,E). Running increased sGAG depletion from
cartilage of the medial compartment of papain-injected
joints at 6 weeks compared with sedentary papain joints
(P < 0.0001). At 12 weeks of follow-up, this difference was
slightly reduced, but attenuation values were still signifi-
cantly higher in running animals (P = 0.03). Running had
no effect on sGAG content in healthy joints. After 6 weeks
of running, the thickness of the medial cartilage was
slightly lower in the papain-injected compared with their
contralateral joint (P = 0.007), and compared with seden-
tary papain joints (P = 0.008). Only after 12 weeks, the car-
tilage in sedentary papain joints slightly degraded and
became thinner compared with the contralateral control
joint (P = 0.004) (Figure 3C,E). The running papain joints,
however, showed clear progression of cartilage degrad-
ation, and at 12 weeks, remained thinner compared with
sedentary papain joints (P < 0.0001).
Attenuation values of lateral compartment cartilage
were lower in running papain joints compared with pa-
pain joints of sedentary animals, indicating a higher
sGAG content (P = 0.03) (Figure 3B). The lateral cartil-
age, however, was thinner in running animals (Figure 3D)
and showed pronounced denudation of subchondral
bone (Figure 3E).
A similar result was seen on histology sections (Figure 4).
These images show that only calcified cartilage remained
intact in the lateral compartment of papain-injected joints
subjected to running.
Subchondral bone changes
In vivo μCT showed that subchondral bone of the medial
tibia plateau increased in thickness during the experiment
in all rats. Subchondral bone thickness in sedentary papain
joints (P = 0.01) and running papain joints (P = 0.01) was
slightly lower after 6 weeks of follow-up compared with
sedentary control joints (Figure 5A). At 6 weeks, subchon-
dral bone plate pores were detected in only sedentary pa-
pain joints (P = 0.003 compared with its contralateral
joint, P = 0.02 compared with running papain joints). In
some animals, these pores became larger, but no signifi-
cant difference was found between sedentary and running
animals at 12 weeks (Figure 5B,G,H).
In sedentary animals, lateral subchondral bone thickness
showed a response similar to the medial compartment:
Figure 3 Cartilage quality and quantity was determined from samples of sedentary (round boxes) and running (square boxes) rats
with equilibrium partitioning of a ionic contrast agent by using (EPIC-)μCT (A-D). The amount of sulfated-glycosaminoglycans (sGAGs)
(arbitrary gray values; A, B) and cartilage thickness (μm; C, D) were measured of medial (A,C) and lateral (B,D) cartilage compartments of the tibial
plateau harvested from control (blank boxes) and sGAG depleted joints (gray boxes). Attenuation values from EPIC-μCT scans are inversely related
to the sGAG content, meaning that a high attenuation corresponds to low sGAG content. Coronal images from representative EPIC-μCT scans of
the tibial plateau show the amount of cartilage (erosions indicated with▼ and dashed lines) and sGAG content (displayed in color) (E). * < 0.05,
**P < 0.01, ***P < 0.001; error bars indicate 95% confidence intervals.
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compared with its contralateral knee joint (P = 0.004 at
6 weeks, and P = 0.003 at 12 weeks). However, in papain-
injected and running joints, lateral subchondral bone
showed a completely different response compared with its
medial component. Here severe subchondral sclerosis de-
veloped after 6 weeks compared with its contralateral knee
joint (P < 0.0001), and this sclerotic appearance persisted
after subsequent 6 weeks of rest (P < 0.0001) (Figure 5C,
G,H). In running animals, a clear increase in subchondral
plate porosity appeared at 6 weeks compared with their
healthy knee joint (P = 0.02) and compared to sedentary
papain joints (P = 0.02). Plate porosity seemed to increase
further at 12 weeks, but this was not significant,. probably
due to the loss of power, because our group size was re-
duced to 10 animals at 12 weeks compared with 20 at
6 weeks.
Trabecular bone underlying the subchondral bone
plate was thinner in sedentary papain joints compared
with its contralateral joint at 6 weeks (P < 0.0001), and
was still thinner at the end of the experiment (P = 0.01).The BV/TV in papain joints of sedentary and running
animals showed a clear loss of bone mass throughout
the experiment.
Control joints of all animals in both experimental
groups showed no sign of patellar osteophyte formation.
In sedentary papain joints and running papain joints, evi-
dent patellar ectopic bone formation was noted at 6
(P < 0.0001) and 12 weeks (P < 0.0001). We also measured
a larger volume of ectopic bone formation in papain run-
ning joints compared with the sedentary papain joints at
both 6 (P < 0.0001) and 12 weeks (P = 0.03) (Figure 6B,C).
Macrophage activation
Animals in both groups received 55 ± 2 MBq (mean ±
SD) of [111In]-DOTA-Bz-folate; no significant difference
was found between both experimental groups. Papain
joints of sedentary rats showed more macrophage activa-
tion measured with DOTA-Bz-Folate SPECT/CT com-
pared with their control knees at 6 weeks (P < 0.0001).
There was still increased macrophage activation at
twelve weeks of follow-up (P = 0.02), but the effect was
Figure 4 Histology of safranin-O-stained sagittal sections of medial and lateral tibia plateau cartilage after 6 weeks and 12 weeks of
follow-up. Both in sedentary and in running animals, cartilage of papain-injected joints was severely sulfated-glycosaminoglycan depleted at
6 weeks and 12 weeks. But in running animals, the extracellular matrix showed clear signs of erosion in the medial compartment and even
denudation of bone in the lateral compartment.
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vation was also higher in their papain-injected joints at 6
(P < 0.0001) and 12 weeks (P = 0.004), but running did
not increase macrophage activation in healthy knee
joints. We calculated absolute differences between non-
papain-injected and papain-injected joints and compared
these values between both experimental groups. Both at
6 (P = 0.03) and 12 weeks (P = 0.03), macrophage activa-
tion was higher in papain-injected joints of running than
in joints of sedentary animals (Figure 6A,C).
Discussion
Papain is a proteolytic enzyme that causes chondroitin
sulfate release from the cartilage [43]. We confirmed the
known effect of intraarticular injections, that papain in-
jections in knee joints of sedentary animals inducedsGAG depletion (Figures 3 and 4) [20]. Besides these
known changes in cartilage, in vivo μCT showed that pa-
pain injections induced a loss of medial subchondral
plate thickness, formation of subchondral plate pores,
and loss of trabecular bone (Figure 5). These aspects
were previously related to early OA development
[28,30]. Additionally, with in vivo folate-receptor-β-tar-
geted SPECT/CT, we found an increased level of acti-
vated synovial macrophages in papain-injected joints of
sedentary animals (Figure 6).
Cytokine-producing activated synovial macrophages
are thought to play a prominent role in osteophyte de-
velopment [44,45]. Papain-injected joints of sedentary
animals also showed clear increased osteophyte forma-
tion. In conclusion, papain injections induced prominent
sGAG loss from cartilage and showed development of
Figure 5 Subchondral bone changes analyzed with longitudinal in vivo μCT in control (white circles) and papain injected (gray
squares) knee joints. Data points were nudged from analyzed time points 0, 6, and 12 weeks for clearer representation of results. Subchondral
plate thickness (Sb. Pl. Th.; A, C) and porosity (Sb. Pl. Por.; B, D) were measured in the medial (A,B) and lateral (C,D) compartments of the tibial
epiphysis. Changes in trabecular thickness (Tb. Th.; E) and trabecular bone volume fraction (BV/TV; F) were measured in tibial epiphysis bone
marrow. (G) Representative sagittal images from binary μCT scans to show most prominent subchondral bone changes, pore development in
medial subchondral bone of papain-injected animals (▼), and development of subchondral sclerosis (dashed line and *) in lateral subchondral
bone of papain-injected and running animals. Three-dimensional top views of the tibial plateau at different time points (H) show subchondral
pore (red color) development in papain animals and papain-plus-running animals. *P < 0.05; **P < 0.01; ***P < 0.001; error bars indicate 95%
confidence intervals.
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early OA progression. However, more tissues in the joint
besides articular cartilage might have had damage due to
repetitive papain injections. Meniscal cartilage is com-
posed of collagen matrix as well as chondroitin sulfate
as its dominant sGAG [46]. Synovium also has sGAG
present within its extracellular matrix of the synovial in-
tima and within the interfibrous matrix [47]. Papaininjections might also have compromised these struc-
tures, but we did not investigate this any further.
In line with other published data, our current study
found no negative effects of exercise on healthy joints of
running animals compared with healthy joints of seden-
tary animals (Figure 3) [7,9]. Thus, this exercise protocol
can be considered a physiological exposure for healthy
sGAG-rich cartilage. Earlier studies reported beneficial
Figure 6 Macrophage activation determined in sedentary (round boxes) and running (square boxes) rats by injection of [111In]-DOTA-
Bz-folate by using SPECT/CT. (A) Quantitative outcome of measured radioactivity in the control (blank boxes) and papain-injected (gray boxes)
knee joints normalized to the size of the cylindrical region of interest (kBq/mm3). Absolute differences per animal were calculated (kBq/mm3) to
reduce interindividual variation (black boxes). A high radioactivity is related to more macrophage activation. (B) Ectopic bone formation (mm3) as
a measure for osteophyte development was quantified on longitudinal bone μCT scans. (C) Sagittal SPECT/CT images of knee joints from
representative animals. CT images shown in black and white were used for anatomic reference; the SPECT images are shown in color. Transaxial
images from patellar bone extracted from binary μCT images show ectopic bone formation (red color). *P < 0.05; **P < 0.01; ***P < 0.001; error bars
indicate 95% confidence intervals.
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and prevention of osteoarthritis [7,9,10,17]. However,
sGAG-depleted cartilage appears highly susceptible for
OA progression when exposed to moderate exercise. In
running animals, sGAG depletion and cartilage thinning
was extensive compared with sedentary controls, and no
protective effect of moderate exercise was found. As
mentioned before, articular cartilage is likely not the
only tissue that had a loss of sGAG due to papain injec-
tions. It can be expected that papain induced degrad-
ation of meniscal cartilage, ligaments and synovium as
well. Possibly, papain induced changes in several joint
tissues and may explain why moderate exercise did not
protect against articular cartilage degradation, and OA
progressed severely in those joints.
Strikingly, a big difference was noted in response be-
tween medial and lateral cartilage. Medial cartilage
showed a clear loss of sGAG and approximately 25% loss
of medial cartilage thickness, whereas within the lateral
compartment, subchondral bone was completely de-
nuded of articular cartilage. Healthy cartilage, though,
also shows a difference between medial and lateralcartilage, and attenuation values of medial cartilage were
about 10% lower compared with lateral cartilage for both
sedentary and running animals. This means that medial
cartilage is likely to have more sGAG in the medial tibia
compartment, which we also found in another study de-
scribed previously [48]. Rats are known to put more
weight on their medial compartment [49]. To withstand
these enhanced loads, chondrocytes within the medial
compartment might produce higher levels of sGAG.
This might be the reason that, after papain injections,
more sGAG remained within this compartment com-
pared with lateral tibia cartilage. As a consequence, lat-
eral cartilage was more susceptible for ECM damage,
which might have been the reason that lateral cartilage
totally eroded.
The enhanced effects of OA in running animals was
not limited to cartilage. OA-related pathology in bone
and macrophage activation was also enhanced in those
joints. Moderate running induced marked changes
within the subchondral bone. In the lateral compart-
ment, the subchondral bone plate increased in thickness
and led to a sclerotic bone phenotype (Figure 5). We
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partment changed the force propagation through the
subchondral bone. The sclerosis formation might be an
attempt to restore subchondral biomechanical stress
levels during the physically active phase, with activation
of osteoblasts that increase the subchondral bone mass
to adapt to increased physical load exposure [50,51]. In-
triguingly, compared with sedentary animals, moderate
exercise protected against a loss of trabecular subchon-
dral bone (Figure 5). It is suggested that loss of trabecu-
lar bone might be due to unloading of the OA-induced
joint because of pain and discomfort for the animals, be-
cause gait alterations have been reported in animals with
experimentally induced OA [52,53].
Exercise plays an important role in the development
and maintenance of bone mass and strength and is
known to protect against bone loss in human patients
with osteoporosis [54,55]. We believe that exercise was
able to exert a similar effect on trabecular subchondral
bone maintenance in our experiments.
As mentioned before, during OA development, the
macrophages within the synovium become activated [35]
and can produce cytokines that enhance osteophyte
growth [44] and mediate cartilage destruction [56]. In
contrast to joints in sedentary animals, papain-injected
joints of running animals had more-pronounced macro-
phage activation and also larger osteophytes (Figure 6).
These results imply that macrophage activation and
osteophyte formation are associated. This was previously
suggested to be mediated by TGF-β and BMP-2, pro-
duced by activated synovial macrophages [44,45]. De-
pending on stimuli in the environment, macrophages
can be activated in different ways. Grossly they can be
subdivided into proinflammatory (M1), wound-healing
(M2a), and regulatory (M2b) phenotypes, with each sub-
type characterized by secretion of different cytokines
and growth factors [57]. The folate-receptor-β is highly
associated with activated macrophages [32,33]. Although
this receptor has a slightly higher predisposition on M2
macrophages, both M1 and M2 subtypes do express
folate-receptor-β [58]. As a consequence, DOTA-Bz-
Folate SPECT/CT cannot address specific subtype macro-
phage activation. Further in vivo studies that modulate
macrophage activation and potentially influence folate-
targeted SPECT signal are required to provide more
insight into the role of macrophage activation and their
cytokine production related to OA development.
Numerous animal models exist for OA. Instability
models like the anterior cruciate ligament transection
(ACLT) model [59], groove model [15,60], the destabilized
meniscus model [61], or meniscectomy model [62]) are
currently most popular. In our opinion, these models rep-
resent an OA etiology related to joint trauma and allows
investigation of early changes during OA development.The results from papain-injected and running animals in
our study closely resemble end-stage OA-like pathology
with pronounced cartilage degradation and subchondral
sclerosis. This aspect of severe OA progression in papain-
injected joints of running animals might be suited to inves-
tigate new treatment strategies designated for regeneration
of cartilage in OA joints. This type of OA induction proved
to be simple and, in combination with exercise-induced
OA in a very reproducible manner with involvement of
cartilage, subchondral bone and synovial macrophages.
Additionally, previous reports show that exposure of rat
knee joints to low-dose papain induce a reversible sGAG
loss from the cartilage [43] and a transient pain response
after injection [24]. This suggests that papain does not dir-
ectly impair chondrocyte viability compared with other
chemically induced OA models, like the mono-iodoacetate
model that can lead to chondrocyte death shortly after in-
jection [63]. Unimpaired cell viability allows future inter-
vention studies to target chondrocytes therapeutically in an
attempt to repair damaged articular cartilage. Although
this study did not investigate chondrocytes viability, and
more research is necessary to elucidate this feature, experi-
mentally induced OA via papain injections might be a
worthwhile contributing model for OA research.
Use of animal models for OA research does not allow
direct translation to human patients. It is known that
skeletal growth in rats is related to changing cartilage
matrix biology and phenotypic characteristics of chon-
drocytes [64,65]. Therefore, many choices (for example,
species, strain, age) related to the study design might
have a distinct influence on experimental outcome. With
this in mind, our results might still be interesting from a
clinical perspective. sGAG is a key molecule for proper
cartilage functioning, and the amount of sGAG content
is an indicator of cartilage health [40]. Loss of sGAG
from articular cartilage is a hallmark of early OA, and it
was hypothesized that this occurs well before OA is de-
tected radiographically [66]. For unknown reasons until
now, a subgroup of OA patients show signs of rapid OA
progression. With radiologic evaluation such as, for ex-
ample, dGEMRIC to determine cartilage sGAG content,
we can investigate whether sGAG depletion and physical
exercise may co-induce severe progression in human pa-
tients as well. More knowledge about cartilage sGAG
content and patient activity level might guide or improve
therapeutic interventions as well. Although physical ex-
ercise can be beneficial for OA patients [67,68], it might
prove to be important that the amount of physical exer-
cise exposure and the intensity level of the activities be
carefully balanced in light of their cartilage sGAG status.
Conclusion
Severe sGAG-depleted cartilage through papain injec-
tions is vulnerable for cartilage damage. Moderate
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in articular cartilage of papain-injected joints, but in-
volved the whole joint with pronounced subchondral
bone adaptation and activation of synovial macrophages.
Additional file
Additional file 1: Figure S1. Animal weight. Weight of all animals at 0,
6, and 12 weeks during the study. Nonrunning control animals (open
circles) that received papain injections only, increased in weight
throughout the study, whereas running animals (shaded boxes) that
received papain injections started to increase in weight after the running
protocol was completed at 6 weeks. Data points are nudged to prevent
overlapping of the data.
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